Transgene signs license agreement with NEC Bio to advance cancer vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. SPY
7. USO
8. AAPL
9. MMED
10. NVDA

Go back to Transgene signs license agreement with NEC Bio to advance cancer vaccine
NEC Corporation (AMEX: NIPNF) Delayed: 30.42 --0 (-0%)
Previous Close $30.42    52 Week High $3.25 
Open $30.42    52 Week Low $2.10 
Day High $30.42    P/E N/A 
Day Low $30.42    EPS $0.00 
Volume 58